📰 Senza System News
Senza System News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Senza System. Real-time updates on events, politics, business and more.
October 16, 2023
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The
May 16, 2022
Trial followed patients with Senza System for 18 months
February 8, 2022
Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.
January 19, 2022
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
November 29, 2021
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
November 29, 2021
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
November 5, 2021
November 1, 2021: Edina, Minn. (PRWEB) November 03, 2021 -- Twin Cities Pain Clinic is now proudly offering spinal cord stimulation (SCS) therapy for the
November 2, 2021
/PRNewswire/ -- NeoSpine is now offering spinal cord stimulation (SCS) procedure(s) for the treatment of painful diabetic neuropathy (PDN). The technology is a...
October 7, 2021
The key companies are investing more towards R&D to develop innovative products since there is a shift from pharmaceutical treatment to medical devices in patients expected to drive the Pain
May 13, 2021
Heres Why You Should Hold on to Nevro (NVRO) Stock Now Zacks.com 5/13/2021 Nevro Corp. NVRO is well poised for growth on the back of its flagship platform Senza and solid international prospects. However, intense competition continues to mar prospects. Popular Searches The stock has gained 22.6% compared with the industry’s growth of 18.2% in a year’s time. Nevro with a market capitalization of $5.25 billion is a medical device company that engages in developing and commercializing a ...